TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BDTX

Black Diamond Therapeutics Inc

Healthcare · Biotechnology

1.90$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

Black Diamond Therapeutics Inc (BDTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 30 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BDTX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.4 -8.5 -25 -52 -100 -85 -67 -62 30
0.0 0.0 0.0 0.1 0.2 0.5 0.4 0.3 0.3
0.0 0.1 3.6 7.8 14 12 9.6 11 6.6
0.5 0.1 10 10 18 12 – – –
1.7 0.4 0.5 5.0 7.0 -9.9 3.7 -2.7 -8.7
0.1 0.1 0.0 0.1 2.7 0.2 0.0 0.0 0.0
-0.1 -0.1 0.0 -282 131 53 16 17 -45
10 52 129 215 0.7 0.2 – – –
-0.1 – – – – – – – –
10.0 52 128 215 0.7 0.2 72 26 -0.1
7.5 44 103 -119 31 -32 22 -20 -15
-2.4 -8.5 -25 -52 -103 -85 -67 -62 30

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?